Details for 2016154617

Up to date per 15.05.2026

Actions

Title / Product Name

VERHINDERUNG UND BEHANDLUNG SYNUKLEINOPATHISCHER UND AMYLOIDOGENER KRANKHEITEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016154617

EP Publication Number

3067066

E-Number

1112229

Language

PCT Number

Publication Date

14.09.2016 A

27.03.2019 B1

Registration Date

27.03.2019

AT Publication Date

15.04.2019

Application Date

22.02.2008

Registration Number

Priorities

23.02.2007

710248

06.04.2007

697646

01.11.2007

984721 P

IPC

A61K 39/395 20060101AFI20180830BHEP

Maximum Duration of Protection

22.02.2028

Owner

Prothena Biosciences Limited77 Sir Rogerson's Quay Block C Grand Canal Docklands Dublin 2, D02 T804IE

The Regents of the University of California1111 Franklin Street, 12th Floor Oakland, CA 94607US

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

SCHENK, Dale B.1542 Los Altos Drive Burlingame, CA 94010US

MASLIAH, Eliezer4661 Corte Mar Corazon San Diego, AZ 92130US

BUTTINI, Manuel, J.Campus Belval Université de Luxemburg 7, Avenue des Hauts Fourneaux L-4362 Esch-sur-AlzetteLU

CHILCOTE, Tamie J.187 Magellan Avenue San Francisco, CA 94116US

ROCKENSTEIN, Edward851 Fordham Avenue Chula Vista, CA 91913US

GAMES, Kate Dora503 Alameda De Las Pulgas Belmont, CA 94002US

Information about Fees